Ardelyx (ARDX) Enterprise Value (2013 - 2026)
Ardelyx (ARDX) reported Enterprise Value of -$238.1 million for Q1 2026, down 11.27% on a YoY basis from -$268.3 million in Q1 2025, and up 10.06% quarter-over-quarter from -$264.7 million in Q4 2025.
Ardelyx (ARDX) Enterprise Value (2013 - 2026) Analysis & Trends
Ardelyx has reported Enterprise Value for 14 years, with the latest figure at -$238.1 million in Q1 2026.
- For the quarter ending Q1 2026, Enterprise Value fell 11.27% year-over-year to -$238.1 million; the trailing twelve-month figure through Mar 2026 stood at -$238.1 million (down 11.27% YoY), and the FY2025 full-year result was -$264.7 million, down 5.83% from the prior year.
- Enterprise Value for Q1 2026 stood at -$238.1 million, up from -$264.7 million in the prior quarter.
- The five-year high for Enterprise Value was -$81.0 million in Q2 2022, with the low at -$264.7 million in Q4 2025.
- Historically, Enterprise Value has averaged -$177.6 million across 5 years, with a median of -$186.0 million in 2024.
- Annual changes were most pronounced in 2022 — Enterprise Value soared 52.85% — and 2023, when it slumped 82.16%.
- Ardelyx's Enterprise Value stood at -$123.9 million in 2022, then tumbled by 48.74% to -$184.3 million in 2023, then plunged by 35.7% to -$250.1 million in 2024, then fell by 5.83% to -$264.7 million in 2025, then grew by 10.06% to -$238.1 million in 2026.
- The last three Enterprise Value figures came in at -$238.1 million (Q1 2026), -$264.7 million (Q4 2025), and -$242.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -32.30 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -4.14 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -286.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -18.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.77 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -7.20 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -7.25 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -584.73 Mn |
| 10 | Ardelyx | 1.49 Bn | 1.25 Bn | 89.66 Mn | -238.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -238.07 Mn |
| Dec 31, 2025 | -264.69 Mn |
| Sep 30, 2025 | -242.71 Mn |
| Jun 30, 2025 | -238.45 Mn |
| Mar 31, 2025 | -213.95 Mn |
| Dec 31, 2024 | -250.10 Mn |
| Sep 30, 2024 | -190.40 Mn |
| Jun 30, 2024 | -185.96 Mn |
| Mar 31, 2024 | -202.58 Mn |
| Dec 31, 2023 | -184.30 Mn |
| Sep 30, 2023 | -165.08 Mn |
| Jun 30, 2023 | -127.58 Mn |
| Mar 31, 2023 | -130.37 Mn |
| Dec 31, 2022 | -123.91 Mn |
| Sep 30, 2022 | -90.62 Mn |
| Jun 30, 2022 | -81.01 Mn |
| Mar 31, 2022 | -89.70 Mn |
| Dec 31, 2021 | -116.69 Mn |
| Sep 30, 2021 | -141.65 Mn |
| Jun 30, 2021 | -171.81 Mn |